We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Fastenal
FAST
$58.7B
| $1.53M | 0.03% |
166,936
+29,824
| +22% | +$296K |
|
|
IVR.PRB
227
DELISTED
INVESCO MORTGAGE CAPITAL INC. 7.75% Fixed-To-Floating Series B Cumulative Redeemable Preferred Stock
IVR.PRB
| $1.51M | 0.03% |
65,600
+9,700
| +17% | +$229K |
|
228
Stryker
SYK
$124B
| $1.49M | 0.03% |
15,871
+597
| +4% | +$59.1K |
|
229
FedEx
FDX
$78.4B
| $1.49M | 0.03% |
10,314
+75
| +0.7% | +$12K |
|
230
State Street Financial Select Sector SPDR ETF
XLF
$56.4B
| $1.48M | 0.03% |
74,568
+22,806
| +44% | +$483K |
|
231
Medtronic
MDT
$115B
| $1.47M | 0.03% |
21,880
+269
| +1% | +$19.8K |
|
|
FULLL
232
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
| $1.44M | 0.03% |
56,300
+6,900
| +14% | +$175K |
|
|
AL
233
DELISTED
Air Lease Corp
AL
| $1.43M | 0.03% |
46,325
-9,580
| -17% | -$319K |
|
234
Tesla
TSLA
$1.4T
| $1.43M | 0.03% |
86,130
-6,525
| -7% | -$111K |
|
235
Franklin Electric
FELE
$4.52B
| $1.42M | 0.03% |
52,107
+17,149
| +49% | +$492K |
|
236
FirstCash
FCFS
$9.72B
| $1.41M | 0.03% |
35,115
+13,801
| +65% | +$565K |
|
|
PSXP
237
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $1.39M | 0.03% |
28,150
-12,325
| -30% | -$716K |
|
238
iShares Russell 1000 Value ETF
IWD
$84B
| $1.38M | 0.03% |
14,821
+4,679
| +46% | +$464K |
|
239
The Mosaic Company
MOS
$7.55B
| $1.36M | 0.03% |
43,647
-575
| -1% | -$23.7K |
|
|
ANSS
240
DELISTED
Ansys
ANSS
| $1.34M | 0.03% |
15,260
-630
| -4% | -$57.9K |
|
241
Johnson Controls International
JCI
$86.1B
| $1.32M | 0.03% |
30,493
+9,811
| +47% | +$452K |
|
|
PX
242
DELISTED
Praxair Inc
PX
| $1.31M | 0.03% |
12,888
+3,239
| +34% | +$357K |
|
243
iShares Europe ETF
IEV
$1.7B
| $1.3M | 0.03% |
32,690
+2,520
| +8% | +$108K |
|
|
AEK.CL
244
DELISTED
Aegon NV
AEK.CL
| $1.3M | 0.03% |
47,166
-1,000
| -2% | -$27.8K |
|
245
Deere & Co
DE
$168B
| $1.3M | 0.03% |
17,526
-195
| -1% | -$17.2K |
|
|
PTR
246
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $1.29M | 0.03% |
18,578
-2,251
| -11% | -$201K |
|
|
HOLX
247
DELISTED
Hologic
HOLX
| $1.29M | 0.03% |
33,008
-3,600
| -10% | -$143K |
|
248
Forward Air
FWRD
$598M
| $1.27M | 0.03% |
+30,530
| New | +$1.44M |
|
249
LKQ Corp
LKQ
$6.42B
| $1.27M | 0.03% |
44,635
-2,900
| -6% | -$88.3K |
|
250
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $1.26M | 0.03% |
35,490
+4,540
| +15% | +$174K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.